Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.81T | 1.63T | 1.58T | 1.42T | 1.33T | Gross Profit |
1.17T | -14.62B | -348.00M | -43.45B | -73.36B | EBIT |
360.71B | 360.57B | 499.40B | 283.13B | 408.54B | EBITDA |
0.00 | 714.01B | 829.75B | 599.09B | 712.74B | Net Income Common Stockholders |
346.13B | 290.34B | 317.38B | 192.38B | 302.70B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.05T | 3.47T | 3.13T | 2.96T | 2.61T | Total Assets |
16.32T | 15.27T | 14.27T | 13.56T | 13.07T | Total Debt |
6.20T | 5.72T | 4.87T | 4.72T | 4.62T | Net Debt |
5.17T | 4.49T | 3.91T | 3.77T | 3.63T | Total Liabilities |
12.30T | 11.84T | 10.90T | 10.46T | 10.00T | Stockholders Equity |
3.94T | 3.36T | 3.26T | 3.03T | 2.99T |
Cash Flow | Free Cash Flow | |||
42.53B | -166.99B | 186.07B | 341.72B | 49.55B | Operating Cash Flow |
1.24T | 913.09B | 1.10T | 1.10T | 1.04T | Investing Cash Flow |
-1.37T | -1.10T | -808.85B | -1.21T | -1.47T | Financing Cash Flow |
-85.48B | 438.31B | -306.62B | 39.88B | 288.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $47.34B | 10.16 | 28.29% | 1.49% | 9.42% | 128.55% | |
72 Outperform | $3.19B | 3.61 | 136.84% | 9.73% | -5.16% | 59.60% | |
71 Outperform | $20.33B | 7.44 | 18.60% | 1.87% | 1.22% | 4.96% | |
69 Neutral | $21.68B | 8.81 | 10.07% | 3.23% | 0.31% | 34.40% | |
69 Neutral | $10.20B | 24.40 | 3.84% | 3.69% | -2.90% | -43.64% | |
68 Neutral | $5.76B | 10.36 | 17.46% | 8.60% | 9.07% | ― | |
64 Neutral | $12.51B | 9.81 | 7.92% | 16985.69% | 12.67% | -5.98% |